The brain's dopamine source: a rare neuron — only around 400,000 in the whole human brain — clustered in midbrain nuclei such as the substantia nigra and ventral tegmental area, whose dopamine output steers movement, motivation and reward.
Parkinson disease, drug addiction, hyperprolactinemia
Identity & Markers
Two steps of catecholamine synthesis build the transmitter: tyrosine hydroxylase converts tyrosine to L-DOPA, then DOPA decarboxylase yields dopamine.
VMAT2 packs the transmitter into vesicles, the dopamine transporter recovers it after release, and neuromelanin pigment makes the substantia nigra appear black.
Annica Dahlström and Kjell Fuxe mapped the classical dopaminergic cell groups in 1964.
Structure & Location
Cell bodies occupy small clusters: substantia nigra groups A8 and A9, ventral tegmental area A10, and hypothalamic groups A11 through A14.
Long axons form the nigrostriatal pathway to the striatum plus mesolimbic and mesocortical projections.
All are born in the mesodiencephalic floor plate: SHH builds the plate and Wnt signaling starts specification. Ngn2, Ascl1, Lmx1a and En1 then specify progenitors; Otx2 separates ventral tegmental subsets, while En1, Pitx3 and Lmx1a carve out substantia nigra subsets.
Physiological Role
Nigrostriatal neurons supply the striatal dopamine behind motor control and motor-skill learning; their loss produces parkinsonism.
Most midbrain dopamine neurons signal reward prediction error: firing jumps when reward beats prediction, stays flat for predicted reward, dips when it falls short.
Tuberoinfundibular neurons from the arcuate nucleus are the primary neuroendocrine inhibitor of prolactin release.
Interactions
Targets carry five G protein-coupled subtypes: D1-like receptors raise cAMP, D2-like lower it — one transmitter, opposite effects.
Dopamine cannot cross the blood–brain barrier, so forebrain transmitter must be made inside these cells.
Like serotonergic neurons, they modulate targets rather than simply exciting or inhibiting them.
Clinical Relevance
Parkinson disease is defined by loss of substantia nigra pars compacta dopamine neurons; motor signs generally wait until at least 30 percent have died.